ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

This study is currently recruiting participants.
Study NCT00012298.   Last updated on October 22, 2008.   Information provided by National Cancer Institute (NCI)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00012298


Locations
United States, Minnesota
Mayo Clinic Cancer Center     Recruiting
      Rochester, Minnesota, United States, 55905
      Contact: Clinical Trials Office - All Mayo Clinic Locations     507-538-7623        

Sponsors and Collaborators
Mayo Clinic
National Cancer Institute (NCI)

Investigators
Study Chair:     Thomas E. Witzig, MD     Mayo Clinic    
Investigator:     Gregory Wiseman, MD     Mayo Clinic    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers